We are live on ! Find out more
FOLD

Amicus Therapeutics
FOLD

Delisted

FOLD was delisted on the 24th of April, 2026.

Back to rankings

228 hedge funds and large institutions have $3.63B invested in Amicus Therapeutics in 2023 Q3 according to their latest regulatory filings, with 33 funds opening new positions, 95 increasing their positions, 66 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

65% more first-time investments, than exits

New positions opened: 33 | Existing positions closed: 20

45% more call options, than puts

Call options by funds: $14.3M | Put options by funds: $9.83M

44% more repeat investments, than reductions

Existing positions increased: 95 | Existing positions reduced: 66

6% more funds holding

Funds holding: 216 → 228 (+12)

0% more funds holding in top 10

Funds holding in top 10: 7 → 7 (0)

3.95% less ownership

Funds ownership: 107.98% → 104.03% (-4%)

6% less capital invested

Capital invested by funds: $3.86B → $3.63B (-$224M)

Holders
228
Holders Change
+12
Holders Change %
+5.56%
% of All Funds
3.62%
Holding in Top 10
7
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.11%
New
33
Increased
95
Reduced
66
Closed
20
Calls
$14.3M
Puts
$9.83M
Net Calls
+$4.46M
Net Calls Change
-$2.09M

Top Buyers

Rank Fund Capital Flow
1
William Blair Investment Management
William Blair Investment Management
Illinois
+$104M
2
Victory Capital Management
Victory Capital Management
Texas
+$30.3M
3
Fidelity Investments
Fidelity Investments
Massachusetts
+$6.04M
4
American Century Companies
American Century Companies
Missouri
+$5.54M
5
N
Nuveen
North Carolina
+$5.5M

Top Sellers

Rank Fund Capital Flow
1
Deutsche Bank
Deutsche Bank
Germany
-$78.8M
2
Point72 Asset Management
Point72 Asset Management
Connecticut
-$78.1M
3
RG
Redmile Group
California
-$33.8M
4
Morgan Stanley
Morgan Stanley
New York
-$29.8M
5
O
OrbiMed
New York
-$23.3M
Name Holding Trade Value Shares
Change 		Change in
Stake
Federated Hermes
226
Federated Hermes
Pennsylvania
$742 -$813 -63 -51%
RA
227
Rise Advisors
New York
$705 – – –
FFA
228
Farther Finance Advisors
California
$365 +$387 +30 New
HNB
229
Huntington National Bank
Ohio
$12 – – –
O
230
OrbiMed
New York
– -$23.3M -1,856,400 Closed
IHAM
231
Integral Health Asset Management
New York
– -$4.86M -387,000 Closed
Bank of Montreal
232
Bank of Montreal
Ontario, Canada
– -$3.8M -290,517 Closed
Two Sigma Advisers
233
Two Sigma Advisers
New York
– -$2.96M -235,676 Closed
Millennium Management
234
Millennium Management
New York
– -$938K -74,680 Closed
HS
235
HighVista Strategies
Massachusetts
– -$786K -62,581 Closed
E
236
Ergoteles
New York
– -$760K -60,549 Closed
RAM
237
Readystate Asset Management
Illinois
– -$337K -26,840 Closed
CIBC Private Wealth Group
238
CIBC Private Wealth Group
Georgia
– -$307K -24,431 Closed
XT
239
XTX Topco
Cayman Islands
– -$269K -21,416 Closed
NC
240
NinePointTwo Capital
California
– -$251K -19,996 Closed
AIMCA
241
Alberta Investment Management Corp (AIMCo)
Alberta, Canada
– -$170K -13,544 Closed
SOW
242
State of Wyoming
Wyoming
– -$164K -13,049 Closed
CA
243
Calton & Associates
Florida
– -$137K -10,923 Closed
GPA
244
Guerra Pan Advisors
New Jersey
– -$134K -10,665 Closed
HIA
245
Harbor Investment Advisory
Maryland
– -$66.9K -5,324 Closed
PI
246
PineBridge Investments
New York
– -$38.8K -3,091 Closed
QCG
247
Quadrant Capital Group
Ohio
– -$9.11K -725 Closed
VNA
248
Valley National Advisers
Pennsylvania
– -$1K -20 Closed
6 7 8 9
10

FOLD Hedge Fund Activity: Q3 2023 in Review

228 of the 6,302 institutional investors tracked by Wall St. Rank reported a position in Amicus Therapeutics (FOLD) for Q3 2023, worth a combined $3.63B — down 5.8% from $3.86B a quarter earlier.

Buyers outnumbered sellers: 33 funds opened new FOLD positions and 20 closed out — a net gain of 13 holders — while 95 added to existing stakes and 66 trimmed.

The largest buyer was William Blair Investment Management, adding an estimated $104M. The largest seller was Deutsche Bank, cutting an estimated $78.8M.

  • 228 institutional investors held Amicus Therapeutics (FOLD) as of Q3 2023, up from 216 in Q2 2023.
  • Funds reported $3.63B of Amicus Therapeutics stock for Q3 2023, down 5.8% quarter-over-quarter.
  • 33 funds opened new Amicus Therapeutics positions in Q3 2023 and 20 closed out, a net change of +13 holders.
  • The largest Amicus Therapeutics buyer in Q3 2023 was William Blair Investment Management, an estimated $104M added.
  • The largest Amicus Therapeutics seller in Q3 2023 was Deutsche Bank, an estimated $78.8M sold.

Based on aggregated 13F filings for Q3 2023.